Adrenomedullin (ADM) is a multifunctional
peptide regulating cardiovascular homeostasis. We studied the role of ADM in the pathogenesis of
atherosclerosis by investigating changes in ADM and its
receptors - calcitonin receptor-like receptor (CRLR) and
receptor activity-modifying proteins (RAMPs) - in aorta of
apoE-/- mice and the effect of exogenous ADM administration.
ApoE-/- mice were fed an atherogenic diet for 4 weeks, and
apoE-/-+ADM mice were additionally given
subcutaneous injections of ADM, 300ng/kg/h, for 4 weeks.
ApoE-/- mice fed an atherogenic diet showed
hyperlipidemia, a large plaque area and increased vessel wall thickness. The
mRNA expression and
protein level of ADM/ADM receptors were increased in the aorta, compared with C57BL/6J mice. The elevated
mRNA level of CRLR and RAMPs correlated positively with ADM
mRNA level. Radioimmunoassay revealed a higher plasma and aorta ADM content, by 61.6% and 285% (both P<0.01), respectively, in
apoE-/- mice than that in C57BL/6J mice. Exogenous ADM significantly ameliorated
dyslipidemia in
apoE-/- mice. ADM-treated mice showed fewer aortic plaques, decreased plaque area, by 76% (P<0.01), and reduced ratio of plaque area to
luminal area, by 65% (P<0.01), and ultrasonography revealed significantly reduced intima-media thickness of the ascending branch and abdominal aorta. The results suggest that atherosclerotic
apoE-/- mice fed an atherogenic diet showed upregulated endogenous ADM and its receptors, and exogenous ADM treatment ameliorated the
dyslipidemia and vascular atherosclerotic lesions. ADM/ADM receptors might be an important protective system against
atherosclerosis and could become a new target of prevention and
therapy for
atherosclerosis.